Health News
FONT-SIZE Plus   Neg
Share SHARE

Two Diabetes Drugs Linked To Pancreatitis Risk

Two Diabetes Drugs Linked To Pancreatitis Risk

Januvia and Byetta, two common diabetes drugs, may double the risk of developing pancreatitis, says a new study from researchers at Johns Hopkins University. The drugs are sold by Merck and Bristol-Meyers Squibb/Astra-Zeneca, respectively.

For the study lead researcher Sonal Singh and his colleagues reviewed insurance records and found that those hospitalized for pancreatitis were twice as likely to be taking either of the two drugs. "This is the first real study to give an estimate of what the risk is," Singh told Bloomberg earlier this week. "[U]ntil now we just had a few case reports."

The FDA has previously flagged both of these medications as possible contributors to pancreatitis. They also added new warnings to the Byetta label after six patient deaths were linked to the drug in 2008.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Health News

comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.